자궁경암 1411 예에 대한 임상적 고찰 - 12 년간 임상 경험의 재조사 - = Carcinoma of the Uterine Cervix - A Review of 12 Years Clinical Experience -

다국어 초록 (Multilingual Abstract)

The results of a review of 1141 cases of cervical carcinoma at Presbyterian Medical Center from January, 1975 to December, 1986 were as follows: 1. The evidence of cervical carcinoma was 11.8 % in the total number of cancer patients and 28.5 % in the female cancer patients. 2. The means number of patients per year was 117.6 cases. The mean age was 48.5 years old in invasive cervical carcinoma, and 42.1 years in intraepithelial carcinoma. 3. The lower the socioeconomic condition, the higher was the risk of cancer, and patients from rural areas showed higher risks of cancer than those from urban areas. 4. The earlier the age of marriage, the higher was the risk of cancer, but the number of deliveries and abortions was not clear. In Postmenopausal women cervical carcinoma was found in 47.3 % of the cases. 5. In the distribution by histologic type, squamous cell carcinoma was 93.6 % and adenocarcinoma was 6.7 %. The most frequent clinical symptom was postcoital or vaginal spotting and vaginal bleeding (68.0 %). In the majority of cases, the gross findings of the uterine cervix was exophytic mass (42.8 %). The distribution by clinical stages was stage I, 15.8 %; stage II, 49.7 %; stage III, 15.3; stage IV, 3.9 %. 6. The determinate five-year survival rate was as follows; a) In radiation therapy-stage I, 84.0 %; stage II, 60.8 %; stage III, 16.7 %; stage IV, 33.3 % b) In radical surgery-stage I, 86.4 %; stage II, 40.0 % 7. The incidence of carcinoma of the cervical stump was 0.49 %; the mean duration was 8 years. 8. The incidence of cervical carcinoma in pregnant woman was 0.06 % per live births and 0.85 % per cervical carcinoma. The determinate five-year survival rate was 50 %. 9. The recurrence rate in radiation therapy was 15.0 %, in radical surgery was 7.8 %. The most frequent symptom in recurrent cervical carcinoma was vaginal bleeding or spotting; an the majority of cases, the recurrence developed within 24 months (77.0 %). The determinate five-year survival rate was 31.3 %. 10. The most fr